Literature DB >> 27673575

Knowledge Gaps in Cardiovascular Care of Older Adults: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society: Executive Summary.

Michael W Rich1, Deborah A Chyun2, Adam H Skolnick3, Karen P Alexander4, Daniel E Forman5,6, Dalane W Kitzman7, Mathew S Maurer8, James B McClurken9,10, Barbara M Resnick11, Win K Shen12, David L Tirschwell13.   

Abstract

The incidence and prevalence of most cardiovascular disorders increase with age, and cardiovascular disease (CVD) is the leading cause of death and major disability in adults aged 75 and older. Despite the effect of CVD on quality of life, morbidity, and mortality in older adults, individuals aged 75 and older have been markedly underrepresented in most major cardiovascular trials, and virtually all trials have excluded older adults with complex comorbidities, significant physical or cognitive disabilities, frailty, or residence in nursing homes and assisted living facilities. As a result, current guidelines are unable to provide evidence-based recommendations for diagnosis and treatment of older adults typical of those encountered in routine clinical practice. The objectives of this scientific statement are to summarize current guideline recommendations as they apply to older adults, identify critical gaps in knowledge that preclude informed evidence-based decision-making, and recommend future research to close existing knowledge gaps. To achieve these objectives, a detailed review was conducted of current American College of Cardiology/American Heart Association (ACC/AHA) and American Stroke Association (ASA) guidelines to identify content and recommendations that explicitly targeted older adults. A pervasive lack of evidence to guide clinical decision-making in older adults with CVD was found, as well as a paucity of data on the effect of diagnostic and therapeutic interventions on outcomes that are particularly important to older adults, such as quality of life, physical function, and maintenance of independence. Accordingly, there is a critical need for a multitude of large population-based studies and clinical trials that include a broad spectrum of older adults representative of those seen in clinical practice and that incorporate relevant outcomes important to older adults in the study design. The results of these studies will provide the foundation for future evidence-based guidelines applicable to older adults and enhance person-centered care of older individuals with CVD in the United States and around the world.
© 2016, Copyright the Authors Journal compilation © 2016, The American Geriatrics Society.

Entities:  

Mesh:

Year:  2016        PMID: 27673575     DOI: 10.1111/jgs.14576

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  22 in total

1.  "Doc, I Think My Meds Are Killing Me! Please Help…": Transdisciplinary Forces Unite to Refocus Pharmacotherapy for Older Adults.

Authors:  Daniel E Forman; Susan J Zieman
Journal:  J Am Geriatr Soc       Date:  2018-12-07       Impact factor: 5.562

2.  Outcomes of "diabetes-friendly" vs "diabetes-unfriendly" β-blockers in older nursing home residents with diabetes after acute myocardial infarction.

Authors:  Andrew R Zullo; Michelle Hersey; Yoojin Lee; Sadia Sharmin; Elliott Bosco; Lori A Daiello; Nishant R Shah; Vincent Mor; W John Boscardin; Christine M Berard-Collins; David D Dore; Michael A Steinman
Journal:  Diabetes Obes Metab       Date:  2018-07-22       Impact factor: 6.577

3.  Intrauterine exposure to diabetes and risk of cardiovascular disease in adolescence and early adulthood: a population-based birth cohort study.

Authors:  Laetitia Guillemette; Brandy Wicklow; Elizabeth A C Sellers; Allison Dart; Garry X Shen; Vernon W Dolinsky; Joseph W Gordon; Davinder S Jassal; Nathan Nickel; Todd A Duhamel; Dan Chateau; Heather J Prior; Jonathan McGavock
Journal:  CMAJ       Date:  2020-09-28       Impact factor: 8.262

4.  Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019.

Authors:  Gilson Soares Feitosa-Filho; José Maria Peixoto; José Elias Soares Pinheiro; Abrahão Afiune Neto; Afonso Luiz Tavares de Albuquerque; Álvaro César Cattani; Amit Nussbacher; Ana Amelia Camarano; Angela Hermínia Sichinels; Antonio Carlos Sobral Sousa; Aristóteles Comte de Alencar Filho; Claudia F Gravina; Dario Celestino Sobral Filho; Eduardo Pitthan; Elisa Franco de Assis Costa; Elizabeth da Rosa Duarte; Elizabete Viana de Freitas; Emilio Hideyuki Moriguchi; Evandro Tinoco Mesquita; Fábio Fernandes; Gilson Soares Feitosa; Humberto Pierre; Ilnei Pereira Filho; Izo Helber; Jairo Lins Borges; Jéssica Myrian de Amorim Garcia; José Antonio Gordillo de Souza; José Carlos da Costa Zanon; Josmar de Castro Alves; Kalil Lays Mohallem; Laura Mariana de Siqueira Mendonça Chaves; Lídia Ana Zytynski Moura; Márcia Cristina Amélia da Silva; Maria Alice de Vilhena Toledo; Maria Elisa Lucena Sales de Melo Assunção; Mauricio Wajngarten; Mauro José Oliveira Gonçalves; Neuza Helena Moreira Lopes; Nezilour Lobato Rodrigues; Paulo Roberto Pereira Toscano; Pedro Rousseff; Ricardo Antonio Rosado Maia; Roberto Alexandre Franken; Roberto Dischinger Miranda; Roberto Gamarski; Ronaldo Fernandes Rosa; Silvio Carlos de Moraes Santos; Siulmara Cristina Galera; Stela Maris da Silva Grespan; Teresa Cristina Rogerio da Silva; William Antonio de Magalhães Esteves
Journal:  Arq Bras Cardiol       Date:  2019-06-06       Impact factor: 2.000

Review 5.  Antiplatelet agents in uncertain clinical scenarios-a bleeding nightmare.

Authors:  Sean Esmonde; Divyesh Sharma; Aaron Peace
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

6.  Using health-related quality of life to predict cardiovascular disease events.

Authors:  Laura C Pinheiro; Evgeniya Reshetnyak; Madeline R Sterling; Joshua S Richman; Lisa M Kern; Monika M Safford
Journal:  Qual Life Res       Date:  2019-01-10       Impact factor: 4.147

7.  Age, knowledge, preferences, and risk tolerance for invasive cardiac care.

Authors:  Michael G Nanna; Eric D Peterson; Angie Wu; Tina Harding; Anthony N Galanos; Lisa Wruck; Karen P Alexander
Journal:  Am Heart J       Date:  2019-10-23       Impact factor: 4.749

8.  Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease.

Authors:  Nanette K Wenger; Caroline Lloyd Doherty; Jerry H Gurwitz; Glenn A Hirsch; Holly M Holmes; Matthew S Maurer; Michael D Murray
Journal:  Drugs Aging       Date:  2017-11       Impact factor: 3.923

9.  Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons.

Authors:  Carlos A Vaz Fragoso; Peter H Van Ness; Terrence E Murphy; Gail J McAvay
Journal:  Respir Med       Date:  2018-02-27       Impact factor: 3.415

10.  FEV1 as a Standalone Spirometric Predictor and the Attributable Fraction for Death in Older Persons.

Authors:  Carlos A Vaz Fragoso; Peter H Van Ness; Gail J McAvay
Journal:  Respir Care       Date:  2019-10-29       Impact factor: 2.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.